SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
廖妙菱
Lv1
50 积分
2021-01-08 加入
最近求助
最近应助
互助留言
RNAi-based drug design: considerations and future directions
5天前
已完结
Targeting KRAS in cancer
6天前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
11天前
已完结
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
11天前
已完结
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
11天前
已完结
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer
11天前
已完结
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
25天前
已完结
143D, a novel selective KRASG12C inhibitor exhibits potent antitumor activity in preclinical models
1个月前
已完结
Clinical significance of cadherin-6 expression in primary and recurrent epithelial ovarian cancer and its association with outcomes: A potential therapeutic target for epithelial ovarian cancer (206)
1个月前
已完结
RNAi-based drug design: considerations and future directions
1个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论